103 related articles for article (PubMed ID: 21726161)
1. Almotriptan for menstrually related migraine.
Bussone G; Allais G; Castagnoli Gabellari I; Benedetto C
Expert Opin Pharmacother; 2011 Aug; 12(12):1933-43. PubMed ID: 21726161
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of almotriptan in menstrual migraine: a comment.
Lionetto L; Fiorillo M; Martelletti P
Expert Opin Pharmacother; 2011 Oct; 12(15):2279-81. PubMed ID: 21916785
[No Abstract] [Full Text] [Related]
4. Pharmacokinetic evaluation of almotriptan for the treatment of migraines.
Negro A; Lionetto L; D'Alonzo L; Casolla B; Marsibilio F; Vignaroli G; Simmaco M; Martelletti P
Expert Opin Drug Metab Toxicol; 2013 May; 9(5):637-44. PubMed ID: 23570251
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiological and pharmacological basis of current drug treatment of migraine headache.
Reddy DS
Expert Rev Clin Pharmacol; 2013 May; 6(3):271-88. PubMed ID: 23656340
[TBL] [Abstract][Full Text] [Related]
6. Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.
Silberstein S; Patel S
Expert Opin Pharmacother; 2014 Oct; 15(14):2063-70. PubMed ID: 25100506
[TBL] [Abstract][Full Text] [Related]
7. Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.
Allais G; Acuto G; Benedetto C; D'Andrea G; Grazzi L; Manzoni GC; Moschiano F; d'Onofrio F; Valguarnera F; Bussone G
Neurol Sci; 2010 Jun; 31 Suppl 1(Suppl 1):S115-9. PubMed ID: 20464599
[TBL] [Abstract][Full Text] [Related]
8. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
9. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
[TBL] [Abstract][Full Text] [Related]
10. Oral almotriptan: practical uses in the acute treatment of migraine.
Dowson AJ
Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
[TBL] [Abstract][Full Text] [Related]
11. Almotriptan for the treatment of acute migraine: a review of early intervention trials.
Antonaci F; De Cillis I; Cuzzoni MG; Allena M
Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858
[TBL] [Abstract][Full Text] [Related]
12. Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
Allais G; Bussone G; D'Andrea G; Moschiano F; d'Onofrio F; Valguarnera F; Manzoni GC; Grazzi L; Allais R; Benedetto C; Acuto G
Cephalalgia; 2011 Jan; 31(2):144-51. PubMed ID: 20660540
[TBL] [Abstract][Full Text] [Related]
13. Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study.
Facchinetti F; Allais G; Nappi RE; Gabellari IC; Di Renzo GC; Genazzani AR; Bellafronte M; Roncolato M; Benedetto C
Gynecol Endocrinol; 2010 Oct; 26(10):773-9. PubMed ID: 20528213
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
15. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
Diener HC
Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
[TBL] [Abstract][Full Text] [Related]
17. Almotriptan in triptan-naïve patients: new evidence of benefits.
Pascual J
Cephalalgia; 2008 Sep; 28 Suppl 2():14-20. PubMed ID: 18715328
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of menstrually related and non-menstrual migraine.
Güven B; Güven H; Çomoğlu S
Acta Neurol Belg; 2017 Sep; 117(3):671-676. PubMed ID: 28560689
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
20. Almotriptan: meeting today's needs in acute migraine treatment.
Láinez MJ
Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
